4 completed, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Lymphocytosis: new trials by email Literature Review of Lymphocytosis trials Research Report on Lymphocytosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Laboratory Biomarker Analysis, Metformin Hydrochloride, Pharmacological Study - Anemia, Fatigue | Phase 1 | Completed | City of Hope Medical Center | 3 | 2017-09-07 | 2026-10-19 |
| Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia Ex Vivo-activated Autologous Lymph Node Lymphocytes, Laboratory Biomarker Analysis - Anemia, Cancer Fatigue | Phase 2 | Completed | M.D. Anderson Cancer Center | 8 | 2015-12-18 | 2019-10-29 |
| B-Cell Hematologic Malignancy Vaccination Registry Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma | Withdrawn | Wake Forest University Health Sciences | 2014-08-01 | 2024-10-03 | ||
| Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Lenalidomide, Ofatumumab - Chronic Lymphocytic Leukemia, Fatigue | Phase 2 | Completed | M.D. Anderson Cancer Center | 36 | 2010-01-19 | 2019-05-07 |
| Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine cyclosporine - Anemia, Leukemia, T-Cell | Phase 1 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 25 | 1996-09-01 | 2006-07-17 |
Leukemia, Lymphocytic, Chronic, B-Cell (4) · Thrombocytopenia (4) · Anemia (3) · Fever (3) · Lymphadenopathy (3) · Fatigue (2) · Multiple Myeloma (2) · Weight Loss (2) · Agammaglobulinemia (1) · Communicable Diseases (1) · Hematologic Neoplasms (1) · Influenza, Human (1) · Leukemia, Large Granular Lymphocytic (1) · Leukemia, Prolymphocytic (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Leukemia (5) · Leukemia, Lymphoid (5) · Leukocyte Disorders (5) · Leukocytosis (5) · Lymphatic Diseases (5) · Lymphoproliferative Disorders (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Blood Platelet Disorders (4) · Chronic Disease (4) · Cytopenia (4)
Cyclosporine (1) · Lenalidomide (1) · Metformin (1) · Quality of Life (1) · Ritonavir (1) · Surveys and Questionnaires (1) · ofatumumab (1)
M.D. Anderson Cancer Center (2) · City of Hope Medical Center (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Wake Forest University Health Sciences (1)
United States (5)
Alessandra Ferrajoli (1) · Chitra Hosing (1) · Michael Thompson, MD, PhD (1) · Nitya Nathwani, MD (1)
P30CA016672 (2)